UPDATE: B.Riley Starts Seelos Therapeutics (SEEL) at Buy
Tweet Send to a Friend
(Updated - March 30, 2021 5:11 AM EDT)
B.Riley analyst Chad Malby initiates coverage on Seelos Therapeutics (NASDAQ: SEEL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Chad Malby initiates coverage on Seelos Therapeutics (NASDAQ: SEEL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
